In which countries is it legal to buy Anamorelin?

Anamorelin(Anamorelin) is an effective drug that has been approved for marketing in many countries around the world. Although it has not yet been officially approved in China, patients can still purchase anamulin from abroad through some legal channels.

Currently, the original drug of anamorelin is mainly developed by Japanese pharmaceutical companies and has been approved in the Japanese market. Japan is the main market for Anamorelin, and patients can purchase Anamorelin at regular local pharmacies or through compliance channels. The specification of Anamorelin in Japan is50mg*100 tablets, and the market price per box is about 4,000 yuan (the specific price will be affected by exchange rate fluctuations). In addition, patients can also purchase from Japanese online pharmacies through other legal means.

In addition to Japan, anamorelin has been approved in clinical trials in some countries and is sold under drug regulatory agencies in some regions. However, patients should carefully choose purchasing channels, ensure that the source of drugs is legal, and consult with their doctors to confirm whether the use of drugs is suitable for personal treatment needs.

It should be noted that, except for Japan, Anamorelin has not been officially launched in other countries such as the United States, Europe and other regions. However, patients in some countries may obtain the drug through cross-border drug purchase or drug purchase platform channels. This approach involves certain legal risks, and patients should understand the drug import regulations of their respective countries.

In addition, the generic version of Anamorelin produced by Laos Lucius Pharmaceutical Factory is also chosen by some patients. The ingredients of this generic drug are basically the same as those of the original drug, and the price is relatively cheap, usually more than 2,000 yuan per box. When purchasing, patients should ensure the legality of the purchasing channel and ensure that the quality of the medicine complies with relevant regulations.

Generally speaking, although anamorelin has not yet been approved for marketing in China, patients can obtain the drug through compliant cross-border drug purchase channels. However, cross-border drug purchases may involve issues such as imports and tariffs. Patients need to understand relevant regulations and evaluate the safety of the drugs before purchasing.

Reference materials:https://synapse.patsnap.com/drug/6dff3a3a53ea42fb8b5eef5c110909f4